IntraBiotics, Pharmacia & Upjohn deal

IntraBiotics received a $1 million milestone payment from P&U for completing Phase I trials of Protegrin IB-367 to treat oral mucositis (see BioCentury, Aug. 31). The product is in Phase II trials. ...